JP Morgan Chase
ALBO

JP Morgan Chase’s Albireo Pharma Inc ALBO Stock Holding History

JP Morgan Chase’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,781
Closed -$233K – 7486
2022
Q4 		$233K Buy
10,781
+1,283
+14% +$27.1K ﹤0.01% 4958
2022
Q3 		$183K Buy
9,498
+190
+2% +$3.93K ﹤0.01% 5001
2022
Q2 		$186K Buy
9,308
+1,298
+16% +$34.2K ﹤0.01% 5111
2022
Q1 		$239K Buy
8,010
+1,341
+20% +$39.3K ﹤0.01% 5101
2021
Q4 		$156K Buy
6,669
+302
+5% +$8.03K ﹤0.01% 5485
2021
Q3 		$199K Sell
6,367
-202
-3% -$6.25K ﹤0.01% 5237
2021
Q2 		$232K Buy
6,569
+154
+2% +$5.01K ﹤0.01% 5160
2021
Q1 		$226K Sell
6,415
-1,118
-15% -$41.3K ﹤0.01% 5103
2020
Q4 		$282K Buy
7,533
+2,575
+52% +$93.6K ﹤0.01% 4683
2020
Q3 		$162K Buy
4,958
+461
+10% +$13.4K ﹤0.01% 4465
2020
Q2 		$119K Sell
4,497
-9,927
-69% -$234K ﹤0.01% 4490
2020
Q1 		$235K Buy
14,424
+5,333
+59% +$117K ﹤0.01% 4215
2019
Q4 		$231K Buy
9,091
+5,524
+155% +$110K ﹤0.01% 4602
2019
Q3 		$71K Buy
3,567
+731
+26% +$18.9K ﹤0.01% 5027
2019
Q2 		$90K Buy
2,836
+614
+28% +$20.5K ﹤0.01% 4970
2019
Q1 		$72K Sell
2,222
-104
-4% -$2.8K ﹤0.01% 5000
2018
Q4 		$57K Buy
2,326
+216
+10% +$5.71K ﹤0.01% 5039
2018
Q3 		$70K Sell
2,110
-1,001
-32% -$32.7K ﹤0.01% 5076
2018
Q2 		$111K Buy
+3,111
New +$101K ﹤0.01% 4803
2017
Q4 		– Sell
-200
Closed -$4K – 5634
2017
Q3 		$4K Buy
+200
New +$4.77K ﹤0.01% 4824

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's ALBO Position: Q1 2023 in Review

JP Morgan Chase sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 10,781 shares — an estimated $233K sold.

JP Morgan Chase first reported a position in ALBO in Q3 2017 and held it in 20 quarters. The position peaked at $282K in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • JP Morgan Chase reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 10,781 Albireo Pharma Inc shares in Q1 2023, an estimated $233K.
  • JP Morgan Chase first reported a position in Albireo Pharma Inc in Q3 2017 and held it in 20 quarters.
  • JP Morgan Chase's Albireo Pharma Inc position peaked at $282K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.